Abstract
Oxidative stress contributes to chronic inflammation of tissues and plays a central role in immunomodulation, which may lead to autoimmune diseases such as systemic lupus erythematosus (SLE) and antiphospholipid syndrome. Markers of oxidative damage include malondialdehyde (MDA), antioxidant scavengers as glutathione (GSH), and glutathione peroxidase (GSH Px), which all correlate well with SLE disease activity. Amelioration of some clinical manifestations of SLE may be expected by targeting lipid peroxidation with dietary or pharmacological antioxidants.
Here, we describe the detection of the key players of oxidant/antioxidant imbalance in SLE.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Perl A (2009) Emerging new pathways of pathogenesis and targets for treatment in systemic lupus erythematosus and Sjögren’s syndrome. Curr Opin Rheumatol 21:443–447
Sheikh Z, Ahmad R, Sheikh N, Ali R (2007) Enhanced recognition of reactive oxygen species damaged human serum albumin by circulating systemic lupus erythematosus autoantibodies. Autoimmunity 40:512–520
Hassan SZ, Gheita TA, Kenawy SA, Fahim AT, El-Sorougy IM, Abdou MS (2011) Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity. Int J Rheum Dis 14(4):325–331
Mansour RB, Lassoued S, Gargouri B, El Gaid A, Attia H, Fakhfakh F (2008) Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus. Scand J Rheumatol 37:103–108
Wang G, Pierangeli SS, Papalardo E, Ansari GA, Khan MF (2010) Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity. Arthritis Rheum 62:2064–2072
Ben Mansour R, Lassoued S, Elgaied A, Haddouk S, Marzouk S, Bahloul Z et al (2010) Enhanced reactivity to malondialdehyde-modified proteins by systemic lupus erythematosus autoantibodies. Scand J Rheumatol 39:247–253
Tewthanom K, Janwityanuchit S, Totemchockchyakarn K, Panomvana D (2008) Correlation of lipid peroxidation and glutathione levels with severity of systemic lupus erythematosus: a pilot study from single center. J Pharm Pharm Sci 11:30–34
Chung CP, Titova D, Oeser A, Randels M, Avalos I, Milne GL et al (2009) Oxidative stress in fibromyalgia and its relationship to symptoms. Clin Rheumatol 28:435–438
Coaccioli S, Panaccione A, Biondi R, Sabatini C, Landucci P, Del Giorno R et al (2009) Evaluation of oxidative stress in rheumatoid and psoriatic arthritis and psoriasis. Clin Ter 160:467–472
Costenbader KH, Kang JH, Karlson EW (2010) Antioxidant intake and risks of rheumatoid arthritis and systemic lupus erythematosus in women. Am J Epidemiol 172:205–216
Filippin LI, Vercelino R, Marroni NP, Xavier RM (2008) Redox signalling and the inflammatory response in rheumatoid arthritis. Clin Exp Immunol 152:415–422
Uchiyama M, Mihara M (1978) Determination of malonaldehyde precursor in tissue by thiobarbituric acid test. Anal Biochem 86: 271–278
Beutler E, Duron O, Kelley BM (1963) Improved method for the determination of blood glutathione. J Lab Clin Med 61:882–888
Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158
Shah D, Kiran R, Wanchu A, Bhatnagar A (2010) Oxidative stress in systemic lupus erythematosus: relationship to Th1 cytokine and disease activity. Immunol Lett 129:7–12
Zhang Q, Ye DQ, Chen GP, Zheng Y (2010) Oxidative protein damage and antioxidant status in systemic lupus erythematosus. Clin Exp Dermatol 35:287–294
Gergely P Jr, Grossman C, Niland B, Puskas F, Neupane H, Allam F et al (2002) Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum 46:175–190
Morgan PE, Sturgess AD, Davies MJ (2009) Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients. Free Radic Res 43:117–127
Huang WN, Tso TK, Huang HY (2007) Enhanced oxidative status but not corresponding elevated antioxidative status by anticardiolipin antibody and disease activity in patients with systemic lupus erythematosus. Rheumatol Int 27:453–458
Morgan PE, Sturgess AD, Hennessy A, Davies MJ (2007) Serum protein oxidation and apolipoprotein CIII levels in people with systemic lupus erythematosus with and without nephritis. Free Radic Res 41:1301–1312
Acknowledgment
The authors would like to thank Dr. Rehab W El Sisi and Dr. Heba A Gheita for their effort in revising the content of this chapter.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Gheita, T.A., Kenawy, S.A. (2014). Measurement of Malondialdehyde, Glutathione, and Glutathione Peroxidase in SLE Patients. In: Eggleton, P., Ward, F. (eds) Systemic Lupus Erythematosus. Methods in Molecular Biology, vol 1134. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0326-9_14
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0326-9_14
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-0325-2
Online ISBN: 978-1-4939-0326-9
eBook Packages: Springer Protocols